웨어러블 주사기 시장 - 예측(2025-2030년)

The global wearable injectors market is projected to witness a CAGR of 19.84% during the forecast period to reach a total market size of US$25.084 billion by 2030, increasing from US$10.148 billion in 2025.

Wearable injectors represent a significant advancement in medical drug delivery systems. These devices, also known as patch pumps or on-body delivery systems, are designed to be attached directly to the patient to administer medication in a controlled and sustained manner. They are particularly suited for high-volume drugs, medications with high viscosities, and treatments that require regular administration over extended periods. By reducing the need for multiple, often painful manual injections, these devices offer a convenient and user-friendly alternative that enhances patient compliance and quality of life.

The core value proposition of wearable injectors includes ease of use for self-administration, minimal interference with daily activities, improved dose accuracy, and the prevention of needlestick injuries. Furthermore, by enabling patients to manage their treatments outside of clinical settings, these devices help reduce hospital and clinic visits, contributing to lower overall healthcare costs and providing greater autonomy to individuals managing chronic conditions.

Primary Market Growth Drivers

A primary driver for the global wearable injector market is the increasing prevalence of chronic, or non-communicable, diseases worldwide. Conditions such as cancer, cardiovascular diseases, diabetes, and autoimmune disorders require long-term, often frequent, drug administration. Wearable injectors play a crucial role in managing these diseases effectively. They are especially valuable for delivering biologics and other complex therapeutics at prescribed intervals, thereby eliminating the possibility of over- or under-dosing. The convenience they offer not only improves the patient experience but also generates significant time and cost savings by minimizing the need for frequent medical appointments solely for injections.

Concurrent with the rising disease burden, technological advancement and increasing patient awareness are also anticipated to propel market growth. As individuals become more health-conscious and informed about available treatment options, the demand for advanced, patient-centric medical devices rises. Wearable injectors align with this trend by offering discreet and manageable treatment solutions. Technological progress has also been instrumental in reducing manufacturing costs through advanced automation, enabling companies to achieve economies of scale. This cost efficiency allows manufacturers to reinvest in research and development, fostering a cycle of innovation that leads to more sophisticated and accessible devices.

Market Restraints

Despite the promising growth trajectory, a significant restraint on the market is the environmental concern associated with these devices. Wearable injectors are typically designed for single-use and are constructed with plastic components. The large-scale adoption of these devices, coupled with improper disposal practices, can lead to substantial plastic waste. Since not all regions possess robust medical waste management and recycling systems, the improper handling and disposal of used injectors can pose environmental hazards, as plastics take a considerable time to decompose. This ecological impact presents a challenge that the industry must address through sustainable design and end-of-life management strategies.

Key Market Developments and Competitive Landscape

The wearable injectors market is characterized by dynamic activity, with key players engaging in strategic partnerships, acquisitions, and technological enhancements to strengthen their market position and expand their product portfolios. A prominent trend involves collaborations between pharmaceutical companies and specialized device manufacturers. These partnerships aim to co-develop and manufacture integrated drug delivery systems, such as the enFuse(R) wearable injector, focusing on improving the patient experience through discreet, at-home administration.

Companies are also enhancing their service offerings by integrating comprehensive human factors engineering into their development platforms. This approach de-risks the regulatory approval process and accelerates time-to-market for new combination products by ensuring devices are intuitive and safe for patient use.

Strategic acquisitions are another key feature of the market landscape. Leading companies are acquiring firms with complementary technologies, such as automated insulin delivery systems or pharmacy automation solutions. These acquisitions are aimed at creating more comprehensive medication management ecosystems that span from acute care to home settings, improving medication adherence, patient safety, and overall outcomes. The introduction of advanced systems, including tubeless, automated insulin delivery systems integrated with continuous glucose monitors, exemplifies the ongoing innovation aimed at providing seamless and effective chronic disease management.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Wearable Injectors Market Segmentation:

• GLOBAL WEARABLE INJECTORS MARKET BY TYPE
• On-Body Injectors
• Off-Body Injectors
• GLOBAL WEARABLE INJECTORS MARKET BY TECHNOLOGY
• Motor-driven
• Expanding Battery
• Spring-based
• Rotary Pump
• Others
• GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION
• Oncology
• Diabetes
• Cardiovascular Disease
• Autoimmune Disease
• Others
• GLOBAL WEARABLE INJECTORS MARKET BY END-USER
• Hospitals and Clinics
• Ambulatory Surgery Centres
• Home Care Centres
• Other
• GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL WEARABLE INJECTORS MARKET BY TYPE

• 5.1. Introduction
• 5.2. On-Body Injectors
• 5.3. Off-Body Injectors

6. GLOBAL WEARABLE INJECTORS MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. Motor-driven
• 6.3. Expanding Battery
• 6.4. Spring-based
• 6.5. Rotary Pump
• 6.6. Others

7. GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Oncology
• 7.3. Diabetes
• 7.4. Cardiovascular Disease
• 7.5. Autoimmune Disease
• 7.6. Others

8. GLOBAL WEARABLE INJECTORS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals and Clinics
• 8.3. Ambulatory Surgery Centres
• 8.4. Home Care Centres
• 8.5. Other

9. GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Medtronic
• 11.2. Amgen (Acquired by tenebio)
• 11.3. Ypsomed
• 11.4. Insulet Corporation
• 11.5. West Pharmaceutical Services
• 11.6. Becton Dickinson And Company
• 11.7. Enable Injections
• 11.8. United Therapeutics Corporation
• 11.9. F. Hoffmann-La Roche AG
• 11.10. Johnson & Johnson

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations